Table 2.
Comparison of baseline characteristics between the patients with post-TACE AKI and without post-TACE AKI
| With AKI (n=41) | Without AKI (n=412) | p value | |
|---|---|---|---|
| Gender (M/F) | 35/6 | 344/68 | 0.757 |
| Age (years) | 59.66 ± 13.52 | 56.33 ± 11.89 | 0.091 |
| Hypertension (y/n) | 4/37 | 25/387 | 0.358 |
| Diabetes (y/n) | 2/39 | 37/375 | 0.372 |
| NSAIDs (y/n) | 21/20 | 182/230 | 0.387 |
| Diuretics (y/n) | 27/14 | 170/242 | 0.002 |
| No. of intervention | 1.68 ± 0.85 | 1.93 ± 1.51 | 0.299 |
| Radiocontrast agent (Omnipaque) (ml) | 91.46 ± 24.76 | 97.99 ± 22.17 | 0.111* |
| Epirubicin (mg) | 29.27 ± 15.07 | 31.53 ± 12.65 | 0.778 |
| Hb (g/L) | 116.93 ± 15.96 | 122.92 ± 19.53 | 0.058 |
| Hematocrit (%) | 35.05 ± 4.68 | 36.60 ± 5.64 | 0.089 |
| Total bilirubin (mg/dl) | 2.02 ± 1.84 | 1.38 ± 1.33 | 0.033* |
| Serum albumin (g/dl) | 3.32 ± 0.57 | 3.46 ± 0.51 | 0.102 |
| BUN (mg/dl) | 16.73 ± 4.80 | 14.57 ± 5.91 | 0.024 |
| Uric acid (mg/dl) | 5.79 ± 1.82 | 4.76 ± 1.46 | 0.001* |
| Creatinine (mg/dl) | 0.82 ± 0.25 | 0.73 ± 0.21 | 0.011 |
| CO2 (mmol/L) | 23.88 ± 3.11 | 24.70 ± 2.75 | 0.071 |
| Sodium (mmol/L) | 139.71 ± 2.98 | 140.03 ± 3.40 | 0.559 |
| PT (INR) | 1.23 ± 0.22 | 1.19 ± 0.19 | 0.223 |
| Child-Pugh score (A/B+C) | 17/24 | 299/113 | 0.000 |
| Proteinuria (y/n) | 14/27 | 56/356 | 0.001 |
| Hematuria (y/n) | 8/33 | 42/370 | 0.069 |
| Urine gravity | 1.020 ± 0.006 | 1.020 ± 0.007 | 0.525 |
| Urine pH | 6.00 ± 0.62 | 6.08 ± 0.63 | 0.429 |
| Postoperative fluid infusion (L) | 1.402 ± 0.538 | 1.561 ± 0.594 | 0.102 |
| Lipiodol (ml) | 15.13 ± 7.63 | 14.68 ± 8.67 | 0.749 |
*
Welch’s t test was used for calculation because of the unequal variances between samples.